17(S)-HETE
目录号 : KCM12145 CAS No. : 183509-25-3 纯度 : ≥98%
Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. 17-HETE is a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transport in the kidney.17(S)-HETE inhibits proximal tubule ATPase activity by as much as 70% at a concentration of 2 µM.
规格 价格 是否有货 数量
25μg
In-stock
50μg
In-stock
100μg
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

17(S)-HETE is arachidonic acid metabolite through cytochrome P-450 pathways. 17(S)-HETE serves as allosteric activator of the cytochrome P450 1B1 and inhibitor of ATPase, induces cardic hypertrophy.

体外研究

17(S)-HETE (5-20 μM) promotes the development of human cardiac hypertrophy by enhancing the activity and protein levels of CY1B1.

 

Real Time qPCR

Cell Line: AC16
Concentration: 5-20 µM
Incubation Time: 24 hours
Result: Increased β/α-MHC ratio, mRNA levels of β-MHC, ANP and CYP1B1, cell surface area by 124%, 250%, 120%, 210% and 117%, respectively.

Western Blot Analysis

Cell Line: AC16
Concentration: 20 µM
Incubation Time: 24 hours
Result: Increased levels of CYP1B1.
体内研究

17(S)-HETE (1-20 μg, arterial injection) inhibits proximal tubular ATPase activity in New Zealand white rabbits.

 

Animal Model: New Zealand White rabbit
Dosage: 1-20 μg
Administration: injection into artery
Result:
Inhibited more than 70% ATPase activity at the concentration of 2 μM.
 
分子式
C20H32O3
分子量
320.47
CAS号
183509-25-3
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积:

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。